Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

Abstract

The stress hormone–regulating hypothalamic-pituitary-adrenal (HPA) axis has been implicated in the causality1 as well as the treatment of depression2. To investigate a possible association between genes regulating the HPA axis and response to antidepressants and susceptibility for depression, we genotyped single-nucleotide polymorphisms in eight of these genes in depressed individuals and matched controls. We found significant associations of response to antidepressants and the recurrence of depressive episodes with single-nucleotide polymorphisms in FKBP5, a glucocorticoid receptor–regulating cochaperone of hsp-90, in two independent samples. These single-nucleotide polymorphisms were also associated with increased intracellular FKBP5 protein expression, which triggers adaptive changes in glucocorticoid receptor and, thereby, HPA-axis regulation. Individuals carrying the associated genotypes had less HPA-axis hyperactivity during the depressive episode. We propose that the FKBP5 variant–dependent alterations in HPA-axis regulation could be related to the faster response to antidepressant drug treatment and the increased recurrence of depressive episodes observed in this subgroup of depressed individuals. These findings support a central role of genes regulating the HPA axis in the causality of depression and the mechanism of action of antidepressant drugs.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: LD structure of the FKBP5 region and association of SNPs in this region with response to antidepressants.
Figure 2: Association of rs1360780 and response over the first 5 weeks of antidepressant treatment.
Figure 3: Number of previous depressive episodes and rs1360780 genotype.
Figure 4: Association of rs1360780 genotypes and FKBP5 protein and mRNA levels.
Figure 5: Association of rs1360780 genotype and neuroendocrine measures in depressed individuals.

Similar content being viewed by others

References

  1. Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477–501 (2000).

    Article  CAS  Google Scholar 

  2. Nemeroff, C.B. & Owens, M.J. Treatment of mood disorders. Nat. Neurosci. 5, 1068–1070 (2002).

    Article  CAS  Google Scholar 

  3. Holsboer, F. & Barden, N. Antidepressants and hypothalamic–pituitary–adrenocortical regulation. Endocr. Rev. 17, 187–205 (1996).

    Article  CAS  Google Scholar 

  4. Nemeroff, C.B. The role of corticotropin–releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 21, 76–82 (1988).

    Article  CAS  Google Scholar 

  5. Nemeroff, C.B. et al. Elevated concentrations of CSF corticotropin–releasing factor–like immunoreactivity in depressed patients. Science 226, 1342–1344 (1984).

    Article  CAS  Google Scholar 

  6. Nemeroff, C.B., Owens, M.J., Bissette, G., Andorn, A.C. & Stanley, M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 45, 577–579 (1988).

    Article  CAS  Google Scholar 

  7. Purba, J.S., Hoogendijk, W.J., Hofman, M.A. & Swaab, D.F. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry 53, 137–143 (1996).

    Article  CAS  Google Scholar 

  8. Timpl, P. et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin–releasing hormone receptor. Nat. Genet. 19, 162–166 (1998).

    Article  CAS  Google Scholar 

  9. Muller, M.B. et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 6, 1100–1107 (2003).

    Article  Google Scholar 

  10. Pariante, C.M. & Miller, A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49, 391–404 (2001).

    Article  CAS  Google Scholar 

  11. Barden, N., Stec, I.S., Montkowski, A., Holsboer, F. & Reul, J.M. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology 66, 212–220 (1997).

    Article  CAS  Google Scholar 

  12. Pratt, W.B. & Toft, D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306–360 (1997).

    CAS  PubMed  Google Scholar 

  13. Cheung, J. & Smith, D.F. Molecular chaperone interactions with steroid receptors: an update. Mol. Endocrinol. 14, 939–946 (2000).

    Article  CAS  Google Scholar 

  14. Schmidt, U. et al. Essential role of the unusual DNA-binding motif of BAG-1 for inhibition of the glucocorticoid receptor. J. Biol. Chem. 278, 4926–4931 (2003).

    Article  CAS  Google Scholar 

  15. Freedman, M.L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388–393 (2004).

    Article  CAS  Google Scholar 

  16. Schiene-Fischer, C. & Yu, C. Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases. FEBS Lett. 495, 1–6 (2001).

    Article  CAS  Google Scholar 

  17. Davies, T.H., Ning, Y.M. & Sanchez, E.R. A new first step in activation of steroid receptors: hormone–induced switching of FKBP51 and FKBP52 immunophilins. J. Biol. Chem. 277, 4597–4600 (2002).

    Article  CAS  Google Scholar 

  18. Denny, W.B., Valentine, D.L., Reynolds, P.D., Smith, D.F. & Scammell, J.G. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 141, 4107–4113 (2000).

    Article  CAS  Google Scholar 

  19. Reynolds, P.D. et al. Glucocorticoid-resistant B-lymphoblast cell line derived from the Bolivian squirrel monkey (Saimiri boliviensis boliviensis). Lab. Anim. Sci. 48, 364–370 (1998).

    CAS  PubMed  Google Scholar 

  20. Scammell, J.G., Denny, W.B., Valentine, D.L. & Smith, D.F. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen. Comp. Endocrinol. 124, 152–165 (2001).

    Article  CAS  Google Scholar 

  21. Vermeer, H., Hendriks-Stegeman, B.I., van der Burg, B., van Buul-Offers, S.C. & Jansen, M. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J. Clin. Endocrinol. Metab. 88, 277–284 (2003).

    Article  CAS  Google Scholar 

  22. Heuser, I., Yassouridis, A. & Holsboer, F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28, 341–356 (1994).

    Article  CAS  Google Scholar 

  23. Wittchen, H. et al. Screening for mental disorders: performance of the Composite International Diagnostic – Screener (CID–S). Int. J. Methods Psychiatr. Res. 8, 59–70 (1999).

    Article  Google Scholar 

  24. Zobel, A.W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F. & Ising, M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. J. Psychiatr. Res. 35, 83–94 (2001).

    Article  CAS  Google Scholar 

  25. Fisher, R.A. Statistical Methods for Research Workers (Oliver and Boyd, London, 1932).

    Google Scholar 

  26. Dudbridge, F. & Koeleman, B.P. Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies. Am. J. Hum. Genet. 75, 424–435 (2004).

    Article  CAS  Google Scholar 

  27. Neale, B.M. & Sham, P.C. The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 75, 353–362 (2004).

    Article  CAS  Google Scholar 

  28. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).

    Article  CAS  Google Scholar 

  29. Lewontin, R.C. On measures of gametic disequilibrium. Genetics 120, 849–852 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Holsboer, F., Lauer, C.J., Schreiber, W. & Krieg, J.C. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology, 62, 340–347 (1995).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank G. Ernst, G. Gajeswski, J. Huber, C. Stallwanger and A. Tontsch for their excellent technical help and Dr. M.E. Keck for helpful discussions. This study was supported in part by the German Ministry of Education and Research (BMBF) within the National Genome Research Network (NGFN) and the Bavarian Ministry of Commerce.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elisabeth B Binder.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Table 1

Information on location of SNPs on the UCSC genome build version hg15, heterozygosity and Hardy-Weinberg equilibrium. (PDF 17 kb)

Supplementary Table 2

Association of confounding variables with response to antidepressant treatment and rs1360780 genotype. (PDF 4 kb)

Supplementary Note

Assessment of population stratification. (PDF 20 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Binder, E., Salyakina, D., Lichtner, P. et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36, 1319–1325 (2004). https://doi.org/10.1038/ng1479

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1479

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing